Location
France, Europe
Check Size
$2M - $10M
Investment Stage
Focus Areas
About Investor
Jean-Christophe Renondin serves as Managing Partner at Vesalius Biocapital IV, a Luxembourg-based life sciences venture capital investor. The firm focuses on BioTech, Medical Devices, Digital Health, Health IT, and Consumer Health investments at Seed, Series A, and Series B stages, with investment ranges from €2,000,000 to €10,000,000. Vesalius Biocapital IV invests in later-stage companies in drug development, medical devices & diagnostics, and eHealth/mHealth predominantly in Europe.
Similar Investors
Christoph Janz
Pre Seed
,Seed
,Igor Tikhturov
Pre Seed
,Seed
,Pierre-Eric Leibovici
Seed
,Series A
,Joe Bond
Seed
,Elliot Richmond
Pre Seed
,Seed
,Ginny Watsham
Seed
,Series A
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP

Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free